Carib A. Oquendo

Array ( [id] => 6031925 [patent_doc_number] => 20110081650 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-07 [patent_title] => 'FREE NGAL AS A BIOMARKER FOR CANCER' [patent_app_type] => utility [patent_app_number] => 12/756501 [patent_app_country] => US [patent_app_date] => 2010-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 9927 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20110081650.pdf [firstpage_image] =>[orig_patent_app_number] => 12756501 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6560759 [patent_doc_number] => 20100272676 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'CHEMOTHERAPEUTIC AGENTS AS ANTI-CANCER VACCINE ADJUVANTS AND THERAPEUTIC METHODS THEREOF' [patent_app_type] => utility [patent_app_number] => 12/753173 [patent_app_country] => US [patent_app_date] => 2010-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6699 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20100272676.pdf [firstpage_image] =>[orig_patent_app_number] => 12753173 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6262716 [patent_doc_number] => 20100297134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'HUMANISED ANTIBODIES WITH ANTI-TUMOUR ACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/725192 [patent_app_country] => US [patent_app_date] => 2010-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 20549 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297134.pdf [firstpage_image] =>[orig_patent_app_number] => 12725192 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6412537 [patent_doc_number] => 20100166755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'ANTI-EGFR ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/723065 [patent_app_country] => US [patent_app_date] => 2010-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12183 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20100166755.pdf [firstpage_image] =>[orig_patent_app_number] => 12723065 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6561759 [patent_doc_number] => 20100272728 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'MAMMALIAN TUMOR SUSCEPTIBILITY GENE PRODUCTS AND THEIR USES' [patent_app_type] => utility [patent_app_number] => 12/721583 [patent_app_country] => US [patent_app_date] => 2010-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10319 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20100272728.pdf [firstpage_image] =>[orig_patent_app_number] => 12721583 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6561768 [patent_doc_number] => 20100272729 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'MAMMALIAN TUMOR SUSCEPTIBILITY GENE PRODUCTS AND THEIR USES' [patent_app_type] => utility [patent_app_number] => 12/721584 [patent_app_country] => US [patent_app_date] => 2010-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10319 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20100272729.pdf [firstpage_image] =>[orig_patent_app_number] => 12721584 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11763027 [patent_doc_number] => 09371386 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-06-21 [patent_title] => 'Methods and compositions for bi-specific targeting of CD19/CD22' [patent_app_type] => utility [patent_app_number] => 13/256812 [patent_app_country] => US [patent_app_date] => 2010-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 20 [patent_no_of_words] => 21074 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13256812 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8094109 [patent_doc_number] => 20120082661 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-05 [patent_title] => 'ANTI-BCMA ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 13/255610 [patent_app_country] => US [patent_app_date] => 2010-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 15893 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20120082661.pdf [firstpage_image] =>[orig_patent_app_number] => 13255610 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8138519 [patent_doc_number] => 20120093808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'HUMANIZED PCRV ANTIBODY HAVING ANTI-PSEUDOMONAL ACTIVITY' [patent_app_type] => utility [patent_app_number] => 13/256219 [patent_app_country] => US [patent_app_date] => 2010-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11924 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20120093808.pdf [firstpage_image] =>[orig_patent_app_number] => 13256219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6636025 [patent_doc_number] => 20100226930 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'Treatment of Leukemias and Chronic Myeloproliferative Diseases with Antibodies to EphA3' [patent_app_type] => utility [patent_app_number] => 12/718768 [patent_app_country] => US [patent_app_date] => 2010-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14761 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20100226930.pdf [firstpage_image] =>[orig_patent_app_number] => 12718768 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6626079 [patent_doc_number] => 20100172864 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'COMPOSITIONS AND METHODS OF USE OF TARGETING PEPTIDES FOR DIAGNOSIS AND THERAPY OF HUMAN CANCER' [patent_app_type] => utility [patent_app_number] => 12/714147 [patent_app_country] => US [patent_app_date] => 2010-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 52821 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20100172864.pdf [firstpage_image] =>[orig_patent_app_number] => 12714147 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6228880 [patent_doc_number] => 20100183618 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'ANTI-EPHA2 ANTIBODY' [patent_app_type] => utility [patent_app_number] => 12/713041 [patent_app_country] => US [patent_app_date] => 2010-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 34814 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20100183618.pdf [firstpage_image] =>[orig_patent_app_number] => 12713041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7652066 [patent_doc_number] => 20110301335 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'ANTI-TNFR1 POLYPEPTIDES, ANTIBODY VARIABLE DOMAINS & ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 13/202349 [patent_app_country] => US [patent_app_date] => 2010-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 46240 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0301/20110301335.pdf [firstpage_image] =>[orig_patent_app_number] => 13202349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9059405 [patent_doc_number] => 08545840 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-01 [patent_title] => 'Methods for treating cancer using an immunotoxin' [patent_app_type] => utility [patent_app_number] => 12/698434 [patent_app_country] => US [patent_app_date] => 2010-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 30148 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12698434 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5958520 [patent_doc_number] => 20110182907 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'Anti-alpha-Enolase I Antibodies for Diagnosis and Treatment of alpha-Enolase I-Associated Diseases' [patent_app_type] => utility [patent_app_number] => 12/695627 [patent_app_country] => US [patent_app_date] => 2010-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8747 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20110182907.pdf [firstpage_image] =>[orig_patent_app_number] => 12695627 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6412111 [patent_doc_number] => 20100166724 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'USES OF THIOREDOXIN' [patent_app_type] => utility [patent_app_number] => 12/694577 [patent_app_country] => US [patent_app_date] => 2010-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 26129 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20100166724.pdf [firstpage_image] =>[orig_patent_app_number] => 12694577 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10193012 [patent_doc_number] => 09221909 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-29 [patent_title] => 'Antibodies against human EPO receptor' [patent_app_type] => utility [patent_app_number] => 13/144671 [patent_app_country] => US [patent_app_date] => 2010-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 5237 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13144671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6289776 [patent_doc_number] => 20100158883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis' [patent_app_type] => utility [patent_app_number] => 12/655717 [patent_app_country] => US [patent_app_date] => 2010-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 21045 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20100158883.pdf [firstpage_image] =>[orig_patent_app_number] => 12655717 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8713481 [patent_doc_number] => 08399621 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-19 [patent_title] => 'Anti-CD4 antibody' [patent_app_type] => utility [patent_app_number] => 12/647698 [patent_app_country] => US [patent_app_date] => 2009-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 25 [patent_no_of_words] => 37026 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12647698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7509949 [patent_doc_number] => 20110256132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'MYOSTATIN BINDING PROTEINS' [patent_app_type] => utility [patent_app_number] => 13/140841 [patent_app_country] => US [patent_app_date] => 2009-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 38675 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20110256132.pdf [firstpage_image] =>[orig_patent_app_number] => 13140841 [rel_patent_id] =>[rel_patent_doc_number] =>)